Consumer group wants halt on review of Lilly drug

By: Matthew Perrone Associated Press Business Writer | WNCT-On Your Side
Published: June 03, 2009

» Comments | Post a Comment

WASHINGTON (AP) - Consumer health advocates and a patent holder on a highly anticipated blood thinner from Eli Lilly want the Food and Drug Administration to halt its review of the drug, which they say may be unsafe at the suggested dose.
The FDA has been reviewing Lilly's prasugrel since January 2008. A company study showed the drug prevents more heart attacks than an older drug, but also causes more internal bleeding.
Consumer watchdog Public Citizen and a research professor who holds a patent on the drug contend that the dose used in that study led to the excess bleeding. They ask the agency to halt its review until new studies are completed.

Reader Comments

*Facebook Account Required to Comment. If you are not already logged into Facebook, please click the comment button to do so.

Deal of the Day

Interactive Radar

Caught On Camera

Hundreds of Marilyn Monroe look-a-likes gather to break world record

A bear and moose take the path less traveled and hundreds of Marilyn Monroe look-a-likes try to break a record. The latest video and stories that will have you talking are coming up now in Take a Look At This!